Rankings
▼
Calendar
MIRM FY 2018 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$17M
EPS (Diluted)
$-0.75
Cash Flow
Operating Cash Flow
-$373,000
Free Cash Flow
-$8M
Stock-Based Comp.
$51,000
Balance Sheet
Total Assets
$52M
Total Liabilities
$62M
Stockholders' Equity
-$10M
Cash & Equivalents
$52M
← Q3 2018
All Quarters
